Medpace Holdings Inc (MEDP)
Pretax margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 335,682 | 318,620 | 317,311 | 303,566 | 282,860 | 265,136 | 237,980 | 218,667 | 201,852 | 200,633 | 192,887 | 180,563 | 168,532 | 150,047 | 132,522 | 136,652 | 124,832 | 117,935 | 113,929 | 100,952 |
Revenue (ttm) | US$ in thousands | 1,899,742 | 1,816,339 | 1,717,384 | 1,607,723 | 1,488,796 | 1,387,029 | 1,289,052 | 1,216,138 | 1,145,156 | 1,094,017 | 1,028,823 | 955,525 | 926,439 | 896,133 | 881,998 | 891,107 | 860,969 | 823,198 | 786,213 | 742,253 |
Pretax margin | 17.67% | 17.54% | 18.48% | 18.88% | 19.00% | 19.12% | 18.46% | 17.98% | 17.63% | 18.34% | 18.75% | 18.90% | 18.19% | 16.74% | 15.03% | 15.34% | 14.50% | 14.33% | 14.49% | 13.60% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $335,682K ÷ $1,899,742K
= 17.67%
The pretax margin of Medpace Holdings Inc has shown stability and consistency in recent quarters. It ranged from 17.80% to 19.42% throughout the provided periods. The highest pretax margin was recorded in Q1 2023 at 19.42%, indicating strong profitability before taxes. Overall, the company has maintained a healthy level of pretax margin, reflecting efficient cost management and profitability in its operations. Further analysis of factors influencing this metric could provide valuable insights into the company's financial health.
Peer comparison
Dec 31, 2023
Company name
Symbol
Pretax margin
Medpace Holdings Inc
MEDP
17.67%
Arrowhead Pharmaceuticals Inc
ARWR
-178.85%
Charles River Laboratories
CRL
14.05%
Exelixis Inc
EXEL
14.07%
Incyte Corporation
INCY
22.59%
IQVIA Holdings Inc
IQV
10.20%